Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 307-316

  Bois, Frédéric Yves ^a  

^a INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

Bayesian; Human; Markov chain Monte Carlo; Mouse; PBPK model; Rat; TCE; Toxicokinetics; Tricholoroethylene; Uncertainty analysis

Indexed keywords

TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAYES THEOREM; CANCER RISK; CONTROLLED STUDY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MODEL; MOUSE; NONHUMAN; PARAMETER; PRIORITY JOURNAL; PROBABILITY; RAT; SAMPLING; STATISTICAL ANALYSIS; STATISTICAL MODEL; TOXICOKINETICS;

ANIMALIA; RODENTIA;

EID: 0033937301     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2307     Document Type: Article

References (47)

1. Clewell HJ III, Gentry PR, Covington TR, Gearhart JM. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment Environ Health Perspect 108(suppl 2):283-305 (2000).
2. Kohn MC. Achieving credibility in risk assessment models. Toxicol Lett 79:107-114 (1995).
3. Charnick SB, Kawai R, Nedelman JR, Lemaire M, Niederberger W, Sato H. Physiologically based pharmacokinetic modeling as a tool for drug development. J Pharmacokinet Biopharm 23:217-229 (1995).
4. Ludden TM, Gillespie WR, Bachman WJ. Commentary on "Physiologically based pharmacokinetic modeling as a tool for drug development." J Pharmacokinet Biopharm 23:231-235 (1995).
5. Louis TA. Assessing, accommodating, and interpreting the influences of heterogeneity. Environ Health Perspect 90:215-222 (1991).
6. Woodruff T, Bois FY. Optimization issues in physiological toxicokinetic modeling - a case study with benzene. Toxicol Lett 69:181-196 (1993).
7. Vozeh S, Steimer JL, Rowland M, Morselli P, Mentre F, Balant LP, Aarons L. The use of population pharmacokinetics in drug development. Clin Pharmacokinet 30:81-93 (1996).
8. Bois FY, Gelman A, Jiang J, Maszle D, Zeise L, Alexeef G. Population toxicokinetics of tetrachloroethylene. Arch Toxicol 70:347-355 (1996).
9. Bois F, Jackson E, Pekari K, Smith M. Population toxicokinetics of benzene Environ Health Perspect 104(suppl 6):1405-1411 (1996).
10. Gelman A, Bois F, Jiang J. Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J Am Stat Assoc 51:1400-1412 (1996).
11. Smith AFM. Bayesian computational methods. Phil Transac Royal Soc London, Series A 337:369-386 (1991).
12. Fisher JW, Allen BC. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. Risk Anal 13:87-95 (1993).
13. Fisher JW, Gargas ML, Allen BC, Andersen ME. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid, in the rat and mouse. Toxicol Appl Pharmacol 109:183-195 (1991).
14. Larson JL, Bull RJ. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol Appl Pharmacol 115:268-277 (1992).
15. Templin MV, Parker JC, Bull RJ. Relative formation of dichloroacetate and trichlcroacetate from trichloroethylene in male B6C3F1 mice (correction/addition). Toxicol Appl Pharmacol 133:177 (1995).
16. Larson JL, Bull RJ. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol Appl Pharmacol 115:278-285 (1992).
17. Prout MS, Provan WM, Green T. Species differences in response to trichloroethylene. I: Pharmacokinetics in rats and mice. Toxicol Appl Pharmacol 79:389-400 (1985).
18. Templin MV, Parker JC, Bull RJ. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol Appl Pharmacol 123:1-8 (1993).
19. Templin MV, Stevens DK, Stenner RD, Bonate PL, Tuman D, Bull RJ. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J Toxicol Environ Health 44:435-447 (1995).
20. Monster AC, Boersma G, Duba WC. Kinetics of trichloroethylene in volunteers; influence of work load and exposure concentration. Int Arch Occup Environ Health 38:87-102 (1975).
21. Monster AC, Boersma G, Duba WC. Kinetics of trichloroethylene in repeated exposure of volunteers. Int Arch Occup Environ Health 42:283-292 (1979).
22. Müller G, Spassovski M, Henschler D. Metabolism of trichloroethylene in man. II: Pharmacokinetics of metabolites. Arch Toxicol 32:283-295 (1974).
23. Müller G, Spassovski M, Henschler D. Metabolism of trichloroethylene in man. III: Interaction of trichloroethylene and ethanol. Arch Toxicol 33:173-189 (1975).
24. Stewart RD, Dodd HC, Gay HH, Erley DS. Experimental human exposure to trichloroethylene. Arch Environ Health 20:64-71 (1970).
25. Bois FY, Maszle D MCSim: a simulation program. J Stat Software 2(9): http://www.stat.ucla.edu/journals/jss/v02/i09 (also available at ftp://sparky.berksley.edu/users/fbois) (1997).
26. Wakefield JC. The Bayesian analysis of population pharmacokinetic models. J Am Stat Assoc 91:62-75 (1995).
27. Davidian M, Giltinan DM. Nonlinear Models for Repeated Measurement Data. London:Chapman & Hall, 1995.
28. Gelman A, Carlin JB, Stern HS, Rubin DB. Bayesian Data Analysis. London:Chapman & Hall, 1995.
29. Gelfand AE, Smith AFM. Sampling-based approaches to calculating marginal densities. J Am Stat Assoc 85:398-409 (1990).
30. Gelfand AE, Hills SE, Racine-Poon A, Smih AFM. Illustration of Bayesian inference in normal data models using Gibbs sampling. J Am Stat Assoc 85 972-985 (1990).
31. Gelfand AE, Smith AFM, Lee T-M. Bayesian analysis of constrained parameter and truncated data problems using Gibbs sampling. J Am Stat Assoc 87:523-532 (1992).
32. Gelman A. Iterative and non-iterative simulation algorithms. Comput Sci Stat 24:433-438 (1992).
33. Tanner MA. Tools for Statistical Inference - Observed Data and Data Augmentation Methods. Vol 67. Berlin:Springer-Verlag, 1991.
34. Wakefield JC, Smith AFM, Racine-Poon A, Gelfand AE. Bayesian analysis of linear and non-linear population models using the Gibbs sampler. Appl Stat - J Royal Stat Soc Series C 43:201-221 (1994).
35. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences (with ciscussion). Stat Sci 7:457-511 (1992).
36. Vesterberg O, Åstrand I. Exposure to trichloroethylene monitored by analysis of metabolites in blood and urine. J Occup Med 18:224-226 (1976).
37. Åstrand I, Övrum P. Exposure to trichlorcethylene. I: Uptake and distribution in man. Scand J Work Environ Health 4:199-211 (1976).
38. Laparé S, Tardif R, Brodeur J. Effect of various exposure scenarios on the biological monitoring of organic solvents in alveolar air. II: 1,1,1-Trichloroethane and trichloroethylene. Int Arch Occup Environ Health 67:375-394 (1995).
39. Sato A, Nakajima T, Fujiwara Y, Murayama N. A pharmacokinetic model to study the excretion of trichloroethylene and its metabolites after an inhalation exposure. Br J Ind Med 34:56-63 (1977).
40. Opdam JJG. Intra and interindividual variability in the kinetics of a poorly and highly metabolising solvent. Br J Ind Med 46:831-845 (1989).
41. Ikeda M, Ohtsuji H, Imamura T, Komoike Y. Urinary excretion of total trichloro-compounds, trichloroethanol, and trichloroacetic acid as a measure of exposure to trichloroethylene and tetrachloroethylene. Br J Ind Med 29:328-333 (1972).
42. Fernandez JG, Droz PO, Humbert BE, Caperos JR. Trichloroethylene exposure - simulation of uptake, excretion, and metabolism using a mathematical model. Br J Ind Med 3443-55 (1977).
43. Guberan E, Fernandez J. Control of industrial exposure to tetrachloroethylene by measuring alveolar concentrations: theoretical approach using a mathematical model. Br J Ind Med 31:159-167 (1974).
44. Fanning E, Bois FY, Rothman N, Bechtold B, Li G, Hayes R, Smith M. Population toxicokinetics of benzene and its metabolites. In: Society of Toxicology Annual Meeting, Cincinnati, Ohio, 1997.
45. Johanson G, Jonsson F, Bois F. Development of new technique for risk assessment using physiologically based toxicokinetic models. Am J Ind Med (suppl 1):101-103 (1999).
46. Bois FY. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ Health Perspect 108(suppl 2):275-282 (2000).
47. Spear R, Bois F. Parameter variability and the interpretation of physiologically based pharmacokinetic modeling results. Environ Health Perspect 102 (suppl 11):61-66 (1994).